Evidence map›Paper›PMID 10662804›Full record

ArticleThe Journal of experimental medicine2000

Somatic hypermutation in MutS homologue (MSH)3-, MSH6-, and MSH3/MSH6-deficient mice reveals a role for the MSH2-MSH6 heterodimer in modulating the base substitution pattern.

M Wiesendanger, B Kneitz, W Edelmann, M D Scharff

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 81 papers.

0numbers the graph read from it
0cells of the map it votes in
81citing papers in PubMed
9.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

81 citing papers in PubMed, 197 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Promoter Proximity Defines Mutation Window for VJournal of immunology (Baltimore, Md. : 1950) · 2022
    Article
  8. Tandem Substitutions in Somatic Hypermutation.Frontiers in immunology · 2021
    Article
  9. Review
  10. Position-Dependent Differential Targeting of Somatic Hypermutation.Journal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article

21 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

M WiesendangerDepartment of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461, USA.
B Kneitz
W Edelmann
M D Scharff
Albert Einstein College of Medicine · US

Funding

DNA MISMATCH REPAIR AND CANCER IN MURINE MODELSR01CA076329 · NCI · YESHIVA UNIVERSITY · PI EDELMANN, WINFRIED · 1998 to 2017
$6.9M
IMMUNOLOGY AND IMMUNUNOOCOLOGY TRAINING PROGRAMT32CA009173 · NCI · YESHIVA UNIVERSITY · PI NATHENSON, STANLEY G · 1985 to 2009
$5.8M
SOMATIC MUTATION OF IG VARIABLE REGIONSR01CA072649 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1997 to 2014
$5.0M
SOMATIC CELL GENETICS OF IG GENESR35CA039838 · NCI · YESHIVA UNIVERSITY · PI SCHARFF, MATTHEW D · 1985 to 1998
–
NCI NIH HHS 5R37CA39838NCI NIH HHS R01 CA072649NCI NIH HHS R01 CA076329NCI NIH HHS R01CA72649NCI NIH HHS R01CA76329NCI NIH HHS T32 CA009173
6 · The paper itself

Abstract

Although the primary function of the DNA mismatch repair (MMR) system is to identify and correct base mismatches that have been erroneously introduced during DNA replication, recent studies have further implicated several MMR components in somatic hypermutation of immunoglobulin (Ig) genes. We studied the immune response in mice deficient in MutS homologue (MSH)3 and MSH6, two mutually exclusive partners of MSH2 that have not been examined previously for their role in Ig hypermutation. In Msh6(-)/- and Msh3(-)/-/Msh6(-)/- mice, base substitutions are preferentially targeted to G and C nucleotides and to an RGYW hot spot, as has been shown previously in Msh2(-)/- mice. In contrast, Msh3(-)/- mice show no differences from their littermate controls. These findings indicate that the MSH2-MSH6 heterodimer, but not the MSH2-MSH3 complex, is responsible for modulating Ig hypermutation.

Indexed as

Adenosine TriphosphatasesATP-Binding Cassette, Sub-Family C ProteinsBase Pair MismatchDNA RepairEscherichia coli ProteinsAnimalsBacterial ProteinsB-LymphocytesDimerizationDNA-Binding ProteinsMiceMutationMutS DNA Mismatch-Binding ProteinMutS Homolog 2 ProteinMutS Homolog 3 ProteinProto-Oncogene ProteinsAdenosine TriphosphatasesATP-Binding Cassette, Sub-Family C ProteinsBacterial ProteinsDNA-Binding ProteinsEscherichia coli ProteinsG-T mismatch-binding proteinMsh2 protein, mouseMSH3 protein, humanMsh6 protein, mousemultidrug resistance-associated protein 1MutS DNA Mismatch-Binding ProteinMutS Homolog 2 ProteinMutS Homolog 3 ProteinMutS protein, E coliProto-Oncogene Proteins

Identifiers

PMID10662804
PMCPMC2195810
OpenAlexW2166617268

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.